Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment


Tuesday, November 22nd 2016

Loeb S, Folkvaljon Y, Robinson D, Schlomm T, Garmo H, Stattin P.

“Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment.”

European Urology. 2015 Dec 29 epub. PMID: 26743040

Link: http://www.ncbi.nlm.nih.gov/pubmed/26743040

Comments are closed.